PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd reported standalone unaudited results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations stood at ₹1,293.61 lakhs, down about 5.8% from ₹1,373.73 lakhs in the same quarter last year. Total revenue was ₹1,293.80 lakhs versus ₹1,373.76 lakhs YoY. The company slipped into a small loss before tax of ₹3.91 lakhs, compared to a profit of ₹39.85 lakhs in Q1 FY25. Loss per share for the quarter was ₹0.11 versus earnings of ₹0.82 in the year-ago quarter. The full FY25 (year ended March 2025) had closed with a loss of ₹146.37 lakhs on revenue of ₹5,351.62 lakhs. The statutory auditor (Mahesh Chandra & Associates) issued an unqualified limited review report.
The results are weak for shareholders — revenue has declined YoY and the company has swung from profit to a small loss in Q1, continuing the loss-making trend seen across FY25. This is likely to be viewed negatively by investors, though the loss is small in absolute terms.